Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 6/20 | 0.59 |
| ▸ | CA2 | P00918 | 6/20 | 0.59 |
| ▸ | CA12 | O43570 | 5/20 | 0.59 |
| ▸ | CA7 | P43166 | 5/20 | 0.59 |
| ▸ | CA9 | Q16790 | 5/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.59 |
| ▸ | SELL | P14151 | 2/20 | 0.54 |
| ▸ | SELP | P16109 | 2/20 | 0.54 |
| ▸ | DPP4 | P27487 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.42 |
| ▸ | CA4 | P22748 | 3/20 | 0.42 |
| ▸ | CA6 | P23280 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KDR | P35968 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30405434 | 1.00 | CA1 (0.59) | CA1CA2CA12CA7CA9 | |
| SCHEMBL2971000 | 0.85 | CA1 (0.68) | CA1CA2CA12CA7CA9 | |
| SCHEMBL29419955 | 0.85 | CA1 (0.68) | CA1CA2CA12CA7CA9 | |
| SCHEMBL11727337 | 0.84 | CA1 (0.48) | CA1CA2CA12CA7CA9 | |
| SCHEMBL157512 | 0.82 | SELL (0.67) | CA1CA2CA12CA7CA9 | |
| SCHEMBL29404142 | 0.82 | SELL (0.67) | CA1CA2CA12CA7CA9 | |
| SCHEMBL29402788 | 0.82 | SELL (0.67) | CA1CA2CA12CA7CA9 | |
| SCHEMBL459866 | 0.82 | SELL (0.67) | CA1CA2CA12CA7CA9 | |
| SCHEMBL3738298 | 0.80 | CA12 (0.50) | CA1CA2CA12CA7CA9 | |
| SCHEMBL6494516 | 0.80 | CA12 (0.50) | CA1CA2CA12CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 396 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4687488-A1 | SWEETNESS AND TASTE IMPROVEMENT OF NON-SUCROSE SWEETENERS WITH HYDROXYBENZOIC ACID | The Coca-Cola Company (US) | 2026-02-11 | — | — | EP | claimed |
| WO-2024206222-A1 | SWEETNESS AND TASTE IMPROVEMENT OF NON-SUCROSE SWEETENERS WITH HYDROXYBENZOIC ACID | THE COCA-COLA COMPANY (US) | 2024-10-03 | — | — | WO | claimed |
| US-12076316-B2 | Levorphanol prodrugs and processes for making and using them | ZEVRA THERAPEUTICS INC. | 2024-09-03 | — | — | US | claimed |
| CN-117750886-A | Salt-containing beverage with improved taste | 可口可乐公司 | 2024-03-22 | — | — | CN | claimed |
| EP-4333641-A1 | BEVERAGES COMPRISING SALTS WITH IMPROVED TASTE | The Coca-Cola Company (US) | 2024-03-13 | — | — | EP | claimed |
| WO-2024033288-A1 | SALICIN DERIVATIVES AS INHIBITORS OF SGLT2 | Société des Produits Nestlé S.A. (CH) | 2024-02-15 | — | — | WO | claimed |
| CN-116836081-A | Ether epoxy toughening agent and preparation method and application thereof | 中国林业科学研究院林产化学工业研究所 | 2023-10-03 | — | — | CN | claimed |
| CN-116135899-A | Light rare earth element isolating agent, modified nano white carbon black thereof and preparation method thereof | 中国石油天然气股份有限公司 | 2023-05-19 | — | — | CN | claimed |
| CN-116135919-A | Environment-friendly solution polymerized styrene-butadiene rubber composition for tire tread and preparation method thereof | 中国石油天然气股份有限公司 | 2023-05-19 | — | — | CN | claimed |
| WO-2022235772-A1 | BEVERAGES COMPRISING SALTS WITH IMPROVED TASTE | THE COCA-COLA COMPANY (US) | 2022-11-10 | — | — | WO | claimed |
| WO-2013063204-A1 | BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROMORPHONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF | KEMPHARM, INC. (US) | 2013-05-02 | — | — | WO | claimed |
| WO-2013016668-A2 | METHYLPHENIDATE-PRODRUGS, PROCESSES OF MAKING AND USING THE SAME | KEMPHARM INC. (US) | 2013-01-31 | — | — | WO | claimed |
| US-20120142719-A1 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof | ALTER DOMUS (US) LLC | 2012-06-07 | — | — | US | claimed |
| EP-2448407-A1 | BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF | Kempharm, Inc. (US) | 2012-05-09 | — | — | EP | claimed |
| US-20110002990-A1 | BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF | ALTER DOMUS (US) LLC | 2011-01-06 | — | — | US | claimed |
| EP-1938367-A2 | DEFECTIVITY AND PROCESS CONTROL OF ELECTROLESS DEPOSITION IN MICROELECTRONICS APPLICATIONS | Enthone, Inc. (US) | 2008-07-02 | — | — | EP | claimed |
| WO-2007035731-A2 | DEFECTIVITY AND PROCESS CONTROL OF ELECTROLESS DEPOSITION IN MICROELECTRONICS APPLICATIONS | ENTHONE INC. (US) | 2007-03-29 | — | — | WO | claimed |
| US-20070062408-A1 | Composition comprising source of deposition ions selected from cobalt and nickel ions, reducing agent for reducing deposition ions onto substrate, and stabilizer comprising molybdenum oxide; for electrolessly depositing cobalt, nickel or alloys thereof onto substrate in manufacture of microelectronics | ENTHONE INC. (US) | 2007-03-22 | — | — | US | claimed |
| WO-2004090054-A1 | GLAZING AND BEDDING COMPOSITIONS | SPECIALISED TECHNOLOGIES LIMITED (NZ) | 2004-10-21 | — | — | WO | claimed |
| EP-0532710-A1 | ANTICORROSIVE, PIGMENTARY COATING COMPOSITION. | FRANCE ETAT (FR) | 1993-03-24 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12076316-B2 | Levorphanol prodrugs and processes for making and using them | OPRM1, OPRL1, OPRK1 | CA1 1503/4885CA2 3018/4885CA12 1814/4885 |
| US-20110002990-A1 | BENZOIC ACID, BENZOIC ACID DERIVATIVES AND HETEROARYL CARBOXYLIC ACID CONJUGATES OF HYDROCODONE, PRODRUGS, METHODS OF MAKING AND USE THEREOF | CYP2B6, CYP3A43, CYP2D6 | CA1 1685/4885CA2 1960/4885CA12 2215/4885 |
| US-20120142719-A1 | Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof | CYP2B6, CYP3A43, CYP2D6 | CA1 1685/4885CA2 1960/4885CA12 2215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.